real-time news and commentary for investors
Thursday, Jun 20
The rate of HPV, a sexually transmitted virus that is the main cause of cervical cancer, has...
The rate of HPV, a sexually transmitted virus that is the main cause of cervical cancer, has dropped 56% among 14-19 year-old young women since the first vaccine was introduced by Merck (MRK) in 2006. The results have been so good that the director of the Centers for Disease Control & Prevention, Thomas Frieden, wants to "protect a generation from cancer" by increasing vaccination. Merck's drug, Gardasil, generated $1.6B in sales in 2012, while one from GlaxoSmithKline (GSK), Cervarix, earned $428M.